跳至主要内容
临床试验/NCT06444737
NCT06444737招募中不适用

Contribution of Ondansetron to Preventing Post-Dural Puncture Headaches Following Spinal Anesthesia for Cesarean Sections : A Randomized Controlled Trial

Mongi Slim Hospital1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2023年11月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
1
主要终点
Incidence of post-dural punction headache (PDPH) during the first seven postoperative days.

研究概览

简要总结

A prospective, bicentric, randomized, double-blind controlled study including parturients scheduled for elective caesarean delivery under spinal anaesthesia and randomized and assigned to one of the two groups:

Group O ondansetron : receiving Intravenous (IV) ondansetron 0.10 mg/ kg diluted in 5 ml normal saline, 5 min before spinal anesthesia Group C control : receiving IV normal saline 5 ml (control group) 5 min before spinal anesthesia

OBJECTIVE :

To evaluate the efficacy of ondansetron in preventing post-dural puncture headache after spinal anaesthesia for caesarean section.

详细描述

Spinal anesthesia is the most common anesthetic technique used for Caesarean sections. However, it is not denied from complications.

Post-dural puncture headache is a major complication of spinal anesthesia, with an incidence ranging from 1.5% to 36%.

OBJECTIVE :

To evaluate the efficacy of ondansetron in preventing post-dural puncture headache after spinal anaesthesia for caesarean section.

the investigators conducted a prospective, bicentric, randomized, double-blind controlled study over a period of 07 months from November 2023 to june 2024.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Aged between 18-45 years
  • Between 37 and 41 weeks of gestation
  • scheduled for elective caesarean delivery under spinal anaesthesia
  • To be delivered by unscheduled caesarean section whose indication does not involve a vital maternal or fetal emergency, according to the Lucas' classification

排除标准

  • All patients who required :
  • more than two attempts for spinal anaesthesia
  • conversion to general anesthesia following failure of spinal anesthesia (defined as a sensory block level <T6) or an intraoperative complication (such as hemorrhage or anaphylactic shock).
  • As well as patients who have subsequently withdrawn their consent for participating to our study.

研究组 & 干预措施

Group O

Experimental

Group ondansetron : parturients receiving intravenous (IV) ondansetron 0.10 mg/ kg diluted in 5 ml normal saline, 5 min before spinal anesthesia

干预措施: Intravenous ondansetron (Drug)

Group C

Placebo Comparator

Group control : receiving IV normal saline 5 ml (control group) 5 min before spinal anesthesia

干预措施: Intravenous normal saline (Drug)

结局指标

主要结局

Incidence of post-dural punction headache (PDPH) during the first seven postoperative days.

时间窗: 7 days

the occurrence of positional headaches at any time postoperatively

次要结局

  • day of PDPH's occurence(7 days)
  • day of PDPH's resolution(7 days)
  • Mean arterial pressure in mmgh(3 days)
  • Need for analgesic treatment due to headaches(7 days)
  • Occurrence of post-operative nausea and/or vomiting(7 days)
  • heart rate(3 days)
  • Headache severity(7 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mhamed Sami Mebazaa

Professor head of anesthesiology and ICU department

Mongi Slim Hospital

研究点 (1)

Loading locations...

相似试验